By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


SEARCH JOBS








Company News
Hemispherx Biopharma (HEB) Director Dr. William Mitchell To Present Research On Treating Deadly Emerging Viruses During The 4th World Congress On Virology October 8 10/7/2014 7:52:29 AM
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators 9/29/2014 8:05:44 AM
Hemispherx Biopharma (HEB) Announces Primate Research Showing Alferon® LDO Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus 9/22/2014 8:00:57 AM
Hemispherx Biopharma (HEB)' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 And H7N9 Influenza HA In Humans 9/15/2014 8:11:04 AM
Hemispherx Biopharma (HEB) And The Swiss Department Of Defense, Civil Protection And Sports Expand Their Collaborative Research Agreement To Include The Study Of Alferon® And Ampligen® Against The Ebola Virus 9/10/2014 8:12:09 AM
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Agree To Collaborate In Studying Alferon® And Ampligen® Against The Ebola Virus 9/8/2014 8:00:40 AM
Hemispherx Biopharma (HEB) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th 9/3/2014 7:51:47 AM
Hemispherx Biopharma (HEB) Announces Financial Results For The Six Months Ended June 30, 2014 8/11/2014 7:45:33 AM
Hemispherx Biopharma (HEB)'s Two Drugs, Ampligen® And Alferon® Ranked Highly In Sensitivity Testing Against MERS/SARS Coronaviruses 8/4/2014 8:24:03 AM
Hemispherx Biopharma (HEB) Achieves High Ranking In Sensitivity Testing Against MERS/SARS Coronaviruses Compared To Other Drugs 7/22/2014 3:36:24 PM
12345678910...
//-->